MedPath

Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents: UH3 Phase

Not Applicable
Active, not recruiting
Conditions
Adolescent HIV Infection
Interventions
Behavioral: Peer navigation
Behavioral: Social Media Engagement
Behavioral: SMS Text messaging
Behavioral: Testing Peer Navigation
Registration Number
NCT04950153
Lead Sponsor
Northwestern University
Brief Summary

Combination interventions with mHealth and Peer Navigation components will be evaluated in a randomized, stepped wedge trial among youth in Ibadan, Lagos, Sagamu, and Jos, Nigeria. Study findings will demonstrate whether or not the combination interventions for HIV testing and linkage to care and for HIV treatment outcomes, which were found to be efficacious in our prior pilot UG3 trial, will remain efficacious if scaled as proposed in this UH3 trial, across multiple sites.

Detailed Description

A randomized stepped wedge (cluster) trial will be conducted to investigate two combination interventions (each with mHealth + Peer Navigation components) among youth in Ibadan, Lagos, Sagamu, and Jos, Nigeria. Study 1 (Testing and Linkage to Care) will test a combination intervention that targets HIV testing and linkage to care. Study 2 (Treatment Intervention) will test a combination intervention that targets HIV treatment outcomes (retention, adherence and viral suppression).

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
558
Inclusion Criteria
  • Living with HIV infection
  • Registered in the study clinics or their satellite clinics
  • On antiretroviral therapy (ART) for at least 3 months
  • Intention to remain a study clinic patient during the study observation and intervention period
Exclusion Criteria
  • Inability to provide informed consent
  • Youths who are 15 years old and not emancipated, who do not have parental consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HIV Treatment InterventionSMS Text messagingCombination HIV treatment outcomes (retention, ART adherence and viral suppression) intervention includes SMS text messaging and peer navigation
HIV Testing InterventionTesting Peer NavigationCombination HIV testing and linkage to care intervention includes social media engagement and peer navigation
HIV Treatment InterventionPeer navigationCombination HIV treatment outcomes (retention, ART adherence and viral suppression) intervention includes SMS text messaging and peer navigation
HIV Testing InterventionSocial Media EngagementCombination HIV testing and linkage to care intervention includes social media engagement and peer navigation
Primary Outcome Measures
NameTimeMethod
VIral suppressionWeek 48

Proportion of participants with viral suppression, defined as viral load (plasma HIV-1 RNA) \<200 copies/ml

Secondary Outcome Measures
NameTimeMethod
Antiretrovial adherence measured by pharmacy drug pick-upWeek 48

Pharmacy drug pick-up (90% of days with medication)

Antiretroviral drug concentrationWeek 48

Antiretroviral drug concentration in Dried Blood Spot sufficient for viral suppression

Retention in careWeek 48

Retention, defined as at least two care (non-study) visits in the prior 24-week period

Trial Locations

Locations (6)

Nigerian Institute of Medical Research (NIMR)

🇳🇬

Lagos, Nigeria

Lagos State University Teaching Hospital

🇳🇬

Lagos, Nigeria

Olabisi Onabanjo University Teaching Hospital

🇳🇬

Sagamu, Nigeria

University of Ibadan

🇳🇬

Ibadan, Nigeria

Lagos University Teaching Hospital

🇳🇬

Lagos, Nigeria

Jos University Teaching Hospital

🇳🇬

Jos, Nigeria

© Copyright 2025. All Rights Reserved by MedPath